Condition
Epstein-Barr Virus clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Epstein-Barr Virus clinical trials that are recruiting, at sites in 4 countries (most in United States (1), Australia (1), China (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Epstein-Barr Virus clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| mRNA-1189 Epstein-Barr (EBV) vaccine in healthy adults 18 to 30 | Phase 1 | Melbourne, Victoria and 1 other locations | Recruiting | Mar 18, 2026 |
| Community spread of multiple infectious diseases in Cambodia from a One Health perspective | — | Phnom Penh, Phnom Penh | Recruiting | Jan 22, 2026 |
| R-MVST cell therapy for viral infections in children and young adults | Phase 1 | New York, New York | Recruiting | Apr 15, 2025 |
| Optimizing screening methods for nasopharyngeal carcinoma using EBV biomarkers | — | Zhuhai, Guangdong | Recruiting | Mar 11, 2025 |
All recruiting trials (4)
-
mRNA-1189 Epstein-Barr (EBV) vaccine in healthy adults 18 to 30
This trial will test whether the mRNA-1189 vaccine is safe and triggers an immune response in healthy adults 18 to 30 when given into the skin or muscle.
-
Community spread of multiple infectious diseases in Cambodia from a One Health perspective
This project will test how common and connected dengue, chikungunya, Zika, Japanese encephalitis, and West Nile infections are among people, animals, and the environment across Cambodia.
-
R-MVST cell therapy for viral infections in children and young adults
This will try giving rapidly generated virus-specific T cells (R-MVST) to children and young adults whose weakened immune systems have recurrent or treatment-resistant infections with EBV, CMV, adenovirus, or BK virus.
-
Optimizing screening methods for nasopharyngeal carcinoma using EBV biomarkers
This study is testing new ways to screen for nasopharyngeal cancer using blood tests for certain virus markers to see if they work better than the current methods for people at high risk.
Related topics
Quick answers
How many Epstein-Barr Virus clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (1 trial), Australia (1 trial), China (1 trial), Cambodia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.